Zhejiang University School of Medicine Researchers Release New Study Findings on Klebsiella pneumoniae (Emergence of high-level colistin resistance mediated by multiple determinants, including mcr-1.1, mcr-8.2 and crrB mutations, combined with...).

Keywords: Antibiotics; Antiinfectives; Colistin; Colistin Therapy; Drugs and Therapies; Enterobacteriaceae; Gammaproteobacteria; Genetics; Glycylcyclines; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Health and Medicine; Klebsiella; Klebsiella pneumoniae; Membrane Proteins; Pharmaceuticals; Polymyxins; Pore Forming Cytotoxic Proteins; Proteobacteria; Tigecycline Therapy EN Antibiotics Antiinfectives Colistin Colistin Therapy Drugs and Therapies Enterobacteriaceae Gammaproteobacteria Genetics Glycylcyclines Gram-Negative Bacteria Gram-Negative Facultatively Anaerobic Rods Health and Medicine Klebsiella Klebsiella pneumoniae Membrane Proteins Pharmaceuticals Polymyxins Pore Forming Cytotoxic Proteins Proteobacteria Tigecycline Therapy 2923 2923 1 03/24/23 20230217 NES 230217 2023 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Klebsiella pneumoniae have been presented. For more information on this research see: Emergence of high-level colistin resistance mediated by multiple determinants, including mcr-1.1, mcr-8.2 and crrB mutations, combined with tigecycline resistance in an ST656 Klebsiella pneumoniae. [Extracted from the article]